登录 | 注册    关注公众号  
微信公众号
搜索
 > 【PTP1B】

PTP1B信息

英文名称:Protein-tyrosine phosphatase 1B
中文名称:蛋白酪氨酸磷酸酶-1B
靶点别称:EC:3.1.3.48,PTPN1,PTP1B,Protein-Tyrosine Phosphatase 1B,Tyrosine-Protein Phosphatase Non-Receptor Type 1,EC 3.1.3.48,PTP-1B,Protein Tyrosine Phosphatase, Non-Receptor Type 1,Protein Tyrosine Phosphatase, Placental,Protein Tyrosine Phosphatase Non-Receptor Type 1
上市药物数量:0
临床药物数量:5
最高研发阶段:临床二期

PTP1B产品列表

产品库
物种
标签
属性
货号 物种 产品描述 蛋白结构 纯度 活性
PTB-H5143
Human
Human PTP1B Protein, His Tag (active enzyme, MALS verified)
ACRO质量管理体系
 
评论(0)
 

PTP1B分子别名

PTP1B

PTP1B分子背景

The protein encoded by this gene is the founding member of the protein tyrosine phosphatase (PTP) family, which was isolated and identified based on its enzymatic activity and amino acid sequence. PTPs catalyze the hydrolysis of the phosphate monoesters specifically on tyrosine residues. Members of the PTP family share a highly conserved catalytic motif, which is essential for the catalytic activity. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP has been shown to act as a negative regulator of insulin signaling by dephosphorylating the phosphotryosine residues of insulin receptor kinase. This PTP was also reported to dephosphorylate epidermal growth factor receptor kinase, as well as JAK2 and TYK2 kinases, which implicated the role of this PTP in cell growth control, and cell response to interferon stimulation. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2013]

PTP1B临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
Razuprotafib AKB-9778; EYP-2301 临床二期 Akebia Therapeutics Inc 新型冠状病毒感染, 开角型青光眼, 成人呼吸窘迫综合征, 高眼压, 糖尿病黄斑水肿, 糖尿病视网膜病变, 视网膜静脉阻塞 详情
ENT-03 ENT-03 临床二期 Enterin Inc 二型糖尿病, 多发性硬化, 阿尔茨海默病, 肥胖症 详情
S-Nitrosoglutathione GSNO; SNO-G; N30-201; NMI-102; N-30-201 临床一期 Nitromed Inc 哮喘 详情
DPM-1003 DPM-1003; DPM1003 临床一期 Maxia Strategies-Europe Ltd Rett综合征 详情
Osunprotafib ABBV-CLS-484; AC-484 临床一期 Calico Life Sciences Llc 实体瘤 详情

消息提示

请输入您的联系方式,再点击提交!

确定